Please login to the form below

Not currently logged in
Email:
Password:

Lemtrada

This page shows the latest Lemtrada news and features for those working in and with pharma, biotech and healthcare.

NICE backtracks on Biogen's multiple sclerosis drug Zinbryta

NICE backtracks on Biogen's multiple sclerosis drug Zinbryta

the disease if they have failed to respond to first-line treatment with Sanofi's Lemtrada (alemtuzumab) or have rapidly evolving severe MS.

Latest news

  • Celebrating excellence Celebrating excellence

    The London-based agency picked up The Cello Health Award for Launch Excellence for work on behalf of Genzyme and its multiple sclerosis treatment Lemtrada. ... Lucid also picked up the Cello Health Award for Launch Excellence Award for supporting Genzyme

  • Lucid behavioural change programmes recognised at PMEA Lucid behavioural change programmes recognised at PMEA

    The London-based agency picked The Cello Health Award for Launch Excellence for work on behalf of Genzyme and its multiple sclerosis treatment Lemtrada. ... Lucid also picked up the Cello Health Award for Launch Excellence Award for supporting Genzyme

  • Sanofi forges $1.5bn cancer partnership with BioNTech Sanofi forges $1.5bn cancer partnership with BioNTech

    and Lemtrada (alemtuzumab) and subsidiary Genzyme's rare disease portfolio.

  • Sanofi plans 18 new product launches by 2020 Sanofi plans 18 new product launches by 2020

    The remainder of its growth portfolio are Cerdelga (eliglustat) for Gaucher disease - the only approved oral, first-line therapy for the rare genetic disease, Lemtrada (alemtuzumab) for multiple sclerosis and sarilumab,

  • Sanofi persuades FDA to back its MS drug Lemtrada Sanofi persuades FDA to back its MS drug Lemtrada

    well-controlled studies that demonstrate the benefits of Lemtrada outweigh its serious adverse effects". ... Lemtrada demonstrated superior efficacy over Rebif on annualised relapse rates in the two studies which were the basis for approval.”.

More from news
Approximately 8 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics